Rajiv Gandhi Cancer Institute and Research Centre

Delhi 110085

2 studies enrolling now · 5 studies all time

What they study most

Colorectal Neoplasms, Lymphoma, Large Cell, Diffuse, Lymphoma, Mixed Cell, Diffuse, Multiple Myeloma, Primary Mediastinal Large B-Cell Lymphoma, Urothelial Cancer

Studies at this site

• A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer — Recruiting now
• A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy — Recruiting now
• Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• CT-011 MAb in DLBCL Patients Following ASCT — Completed